Q8MY85 AF NFT

Fibroblast growth factor receptor 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeieydah5s2pvvphnmh3ghsep4tgkyxlnzwabndrxf6bgks2lxc6jni/metadata.json
IPFS of structure file: 
bafybeibbansf7geasqe5lrlxld3qj2rafvmnorjxttx5xgxuxspxwkc2mi/AF-Q8MY85-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7FDF8b382C6a36A8772D1A265E8e480c7DF0A9C1
First NFT owner address (bech32): 
genesis10l0ckwpvdgm2saedrgn9arjgp37lp2wpyzq5qn
Current NFT ID #129948 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
129948
Accession (UniProt):
Q8MY85
Name::
Fibroblast growth factor receptor 2
Experimental Method:
Predicted structure
Sequence source:
DUGESIA JAPONICA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q8MY85 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q8MY85|FGFR2_DUGJA Fibroblast growth factor receptor 2 OS=Dugesia japonica OX=6161 GN=FGFR2 PE=2 SV=1 MLNKFIVIVTMLAMWNYAQDCNFELSKNETVQFTSFLPLILNCASISKFDTDLCETINDERPYNWYFQNKKIGNETKGKIKLVSSSQQMIIFNGSASDEGNYMCETINNNKEFISKTFDARMIEPSMTQMELLLNSFPNDHQEEINGRIYWLPEMILNHIRDVVIINQGAESDLHSFYYVSGSDSQISTFDVQWYFHYQPKSEDKTIIDHNIKTFYSSCNDLDLLPRKVNGSCYSSRLYLYNVEIKDQGFYSVEATLRMKNGSSHGLNFTYELKINIANILDPDKTNSILSTPQISFNLNSRVCINDRFDWICKVTPVVSYYVTIYKNNSNPNNITVLAESEVLQMNIDGNSGQGFYLKSSTVNYSVNSVQREHAGVYACRIINFKDYSSDHQNRHEPEVLMRLTVKDCVGNSYFTIIWYSISVGIIILVVISFLIIRLYNKYSNGYIVKTVIVQHPNKLYVPHDTCFPLLMPDITIKTIHKHINSSEDSLLQQKHFTNNSNIPFSQKISKYFRKSFIFSYRHVDVSSSNLDSPLGVISNTETNKLTSNSLTVETQRPQLILQNDANTKYILPSNIGWIFSRDSLIIGSKIGEGAFGIVYSALVKSFSENSASVEVAIKTLHTSFGDQDVINLIQELEMMKIIGRHRHIISLYGACIDNGHPYMVIELAKHGNLRDFLRAQRSQSKVGEIQNSGGLVTRLTVTDFLRFSIEIAEGMEYLSSRKIIHRDLAARNVLVDQYVEMKIADFGLTRIVENYYRKTTDGRLPIKWMAPECLLDRVYTVKSDVWSYGIVLWEIFTMGQTPYPTIQSDGMHQALRNGIRNEKPALASDEMYRLMLTIWNDDPLERHTFSEIIDKLTHIQLSNGGSSPKRDYLEISSNQCYSTTIV